6
Oct
2026

Megafine Pharma (P) Ltd.

Exhibitor at CPHI Milan 2026 stand 3F127, API
About Us

Excellence in API Manufacturing
MEGAFINE is a global leader in the pharmaceutical industry, delivering advanced API solutions through state-of-the-art facilities accredited by USFDA, EU-GMP, Australia-TGA, Canada-HC, Korea-MFDS, Japan-PMDA, and Mexico-COFEPRIS. Guided by science and driven by a customer-centric approach, we ensure uncompromising quality and reliability to meet the evolving needs of our global partners.

With 26 US-DMFs, 6 CEPs, and more than 350 global regulatory filings, MEGAFINE supports both innovators and generic companies across globe.  

  • Country/Region:
    India
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    500 - 999
Company types
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Generic APIs producer
Intermediates Manufacturer
Contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 3F127, API

Products Featured at CPHI Milan 2026

  • Ambrisentan

    Product Ambrisentan

    APIbrhrbrThis product is used as an intermediate for Clopidogrel. Contact us for more information.
  • Apixaban

    Product Apixaban

    APIbrhrbrThis product is used as an intermediate for Cinacalcet. Contact us for more information.
  • Apremilast

    Product Apremilast

    APIbrhrbrThis product is used as an intermediate for Solifenacin. Contact us for more information.
  • Asenapine Maleate

    Product Asenapine Maleate

    APIbrhrbrIt is used as an intermediate for Darifenacin. Contact us for more information.
  • Bosentan Monohydrate

    Product Bosentan Monohydrate

    APIbrhrbrThis product is used as an intermediate for Sitagliptin. Contact us for more information.